A Hansoh Bio LLC, Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. patent details piperidinyl indole derivatives acting as complement factor B (CFB) inhibitors.
Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE)-- "Next Generation Complement Therapeutics Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global next-generation complement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results